Azithromycin Tablets
250 · 500 · 1000mg
Formulated to target bacterial infection to mitigate complications.
Covid-19 Support
Covid-19 support medicines cover selected roles such as antiviral treatment, inflammation control, clot-risk management, and respiratory support after serious illness. This category should be read carefully because COVID-19 care changes by severity, timing, and risk group.
Esbriet
200 · 400mg
utilized to manage idiopathic pulmonary fibrosis to alleviate lung fibrosis progression.
Molnunat
200mg
Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.
Nintedanib Capsules
100mg
indicated to alleviate disease progression in idiopathic pulmonary fibrosis, to support respiratory function.
Rivaroxaban Tablets
10mg
Indicated to address blood clot risk and supported to mitigate thromboembolic complications.
What this category helps you sort out
Mild COVID-19, high-risk early infection, hospital-level pneumonia, and long-term lung complications are not the same clinical problem. Medicines that help in one setting can be inappropriate or harmful in another.
The useful question is whether the product targets viral replication, inflammation, bacterial complications, clot risk, or lung scarring. That distinction keeps the category practical rather than a grab bag of respiratory medicines.
How to compare options
- Check the intended setting: early outpatient treatment, hospital care, secondary infection, anticoagulation, or post-illness lung management.
- Look at timing, because some antivirals must be started early to be useful.
- Review oxygen level, breathlessness, chest pain, clot symptoms, pregnancy, immune suppression, and kidney or liver function.
- Do not use antibiotics or steroids for COVID-19 unless a clinician has identified a reason.
Common medication groups
Antivirals
COVID-19 antivirals are generally considered for higher-risk patients and are time-sensitive. Suitability depends on current guidance, interactions, kidney function, and symptom timing.
Corticosteroids and anti-inflammatory medicines
Steroids can help selected patients with significant inflammatory lung disease, especially where oxygen support is needed, but they are not routine treatment for every infection.
Anticoagulants, antibiotics, and lung-support medicines
These medicines address complications rather than the virus itself. They require diagnosis of clot risk, bacterial infection, or ongoing lung disease before use.
Safety notes for this category
Urgent assessment is needed for severe breathlessness, blue lips, confusion, chest pain, oxygen levels that are low, dehydration, or worsening symptoms in a high-risk person.
COVID-19 medicines can have major interactions, especially antivirals with heart, transplant, cholesterol, anticoagulant, and mental health medicines.
Important Safety Information
Covid-19 treatment depends on current guidance, timing, risk status, and disease severity. This page is educational and does not replace testing, urgent care, vaccination advice, or clinician-directed treatment.